Alzamend Neuro ALZN
NASDAQ ALZN
$1.67 -0.04 (-2.34%)
As of: Sep 10, 2026 · 12:03 PM EDT

Alzamend Neuro (ALZN) Non-Current Deferred Tax Liability (2024 - 2026)

Alzamend Neuro's (ALZN) quarterly Non-Current Deferred Tax Liability came in at $14114.0 in Q2 2026, down 40.82% year-over-year from $23848.0 in Q2 2025, and down 40.82% quarter-over-quarter from $23848.0 in Q2 2025.

Analysis

Alzamend Neuro (ALZN) Non-Current Deferred Tax Liability (2024 - 2026) Analysis & Trends

Alzamend Neuro has disclosed Non-Current Deferred Tax Liability across 3 years of filings, most recently posting $14114.0 for Q2 2026.

  • In Q2 2026, Non-Current Deferred Tax Liability fell 40.82% year-over-year to $14114.0; the TTM figure through Apr 2026 stood at $14114.0 (down 40.82% YoY), while the FY2026 annual figure was $14114.0, down 40.82% from the prior year.
  • Non-Current Deferred Tax Liability came in at $14114.0 for Q2 2026 at Alzamend Neuro, down from $23848.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $32400.0 in Q2 2024 to a low of $14114.0 in Q2 2026.
  • Average Non-Current Deferred Tax Liability over 3 years is $23454.0, with a median of $23848.0 recorded in 2025.
  • Year-over-year, Non-Current Deferred Tax Liability slipped 26.4% in 2025 and tumbled 40.82% in 2026.
  • Over 3 years, Non-Current Deferred Tax Liability stood at $32400.0 in 2024, then fell by 26.4% to $23848.0 in 2025, then slumped by 40.82% to $14114.0 in 2026.
  • Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $14114.0 in Q2 2026, $23848.0 in Q2 2025, and $32400.0 in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.51 Bn 192.52 Bn 7.24 Bn
2 Gilead Sciences 179.28 Bn 176.11 Bn 6.22 Bn
3 Vertex Pharmaceuticals 131.06 Bn 123.21 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.61 Bn 73.62 Bn 3.93 Bn
5 Argenx Se 60.71 Bn 55.52 Bn 1.37 Bn
6 Moderna 53.60 Bn 48.46 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.41 Bn 30.10 Bn 992.69 Mn
8 Biogen 31.79 Bn 30.50 Bn 1.96 Bn
9 Roivant Sciences 29.11 Bn 29.11 Bn 1.16 Mn
10 Alzamend Neuro 5.57 Mn 5.57 Mn -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 14,114.00
Apr 30, 2025 23,848.00
Apr 30, 2024 32,400.00